SchizEv

Schizophrenia & Evolution

AHS 2017

AHS 2017: Evolution & Schizophrenia

 

Read the Expanded abstract

 

Illustrations

Illustrations in this presentation with the assistance of Tiny Fox Art and Ideal Illustrations.

Complete References
 

Attard, A., & Larkin, M. (2016). Art therapy for people with psychosis: a narrative review of the literature. The Lancet Psychiatry, 3(11), 1067–1078. http://doi.org/10.1016/S2215-0366(16)30146-8

Avramopoulos, D., Pearce, B. D., McGrath, J., Wolyniec, P., Wang, R., Eckart, N., … Pulver, A. E. (2015). Infection and inflammation in schizophrenia and bipolar disorder: a genome wide study for interactions with genetic variation. PloS One, 10(3), e0116696. http://doi.org/10.1371/journal.pone.0116696

Bailey, J. M. (2000). How can psychological adaptations be heritable? Novartis Foundation Symposium, 233, 171-80–4. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11276902

Baril, L., Ancelle, T., Goulet, V., Thulliez, P., Tirard-Fleury, V., & Carme, B. (1999). Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scandinavian Journal of Infectious Diseases, 31(3), 305–9. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10482062

Bilder, R. M., & Knudsen, K. S. (2014). Creative cognition and systems biology on the edge of chaos. Frontiers in Psychology, 5, 1104. http://doi.org/10.3389/fpsyg.2014.01104

Bressan, P., & Kramer, P. (2016). Bread and Other Edible Agents of Mental Disease. Frontiers in Human Neuroscience, 10, 130. http://doi.org/10.3389/fnhum.2016.00130

Burns, J. K. (2006). Psychosis: A costly by-product of social brain evolution in Homo sapiens. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30(5), 797–814. http://doi.org/10.1016/j.pnpbp.2006.01.006

Burns, J. K. (2009). Reconciling “the new epidemiology” with an evolutionary genetic basis for schizophrenia. Medical Hypotheses, 72(3), 353–358. http://doi.org/10.1016/j.mehy.2008.09.046

Calvo, P., Fortuny, J. R., Guzmán, S., Macías, C., Bowen, J., García, M. L., … Fatjó, J. (2016). Animal Assisted Therapy (AAT) Program As a Useful Adjunct to Conventional Psychosocial Rehabilitation for Patients with Schizophrenia: Results of a Small-scale Randomized Controlled Trial. Frontiers in Psychology, 7, 631. http://doi.org/10.3389/fpsyg.2016.00631

Cascella, N. G., Kryszak, D., Bhatti, B., Gregory, P., Kelly, D. L., Mc Evoy, J. P., … Eaton, W. W. (2011). Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. Schizophrenia Bulletin, 37(1), 94–100. http://doi.org/10.1093/schbul/sbp055

Cederlöf, M., Maughan, B., Larsson, H., D’Onofrio, B. M., & Plomin, R. (2017). Reading problems and major mental disorders - co-occurrences and familial overlaps in a Swedish nationwide cohort. Journal of Psychiatric Research, 91, 124–129. http://doi.org/10.1016/j.jpsychires.2017.03.014

Chabris, C. F., Lee, J. J., Benjamin, D. J., Beauchamp, J. P., Glaeser, E. L., Borst, G., … Laibson, D. I. (2013). Why it is hard to find genes associated with social science traits: theoretical and empirical considerations. American Journal of Public Health, 103 Suppl 1(Suppl 1), S152-66. http://doi.org/10.2105/AJPH.2013.301327

Chiang, M., Natarajan, R., & Fan, X. (2016). Vitamin D in schizophrenia: a clinical review. Evidence Based Mental Health, 19(1), 6–9. http://doi.org/10.1136/eb-2015-102117

Crow, T. J. (2000). Schizophrenia as the price that homo sapiens pays for language: a resolution of the central paradox in the origin of the species. Brain Research. Brain Research Reviews, 31(2–3), 118–29. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10719140

Dauwan, M., Begemann, M. J. H., Heringa, S. M., & Sommer, I. E. (2016). Exercise Improves Clinical Symptoms, Quality of Life, Global Functioning, and Depression in Schizophrenia: A Systematic Review and Meta-analysis. Schizophrenia Bulletin, 42(3), 588–99. http://doi.org/10.1093/schbul/sbv164

De Santis, A., Addolorato, G., Romito, A., Caputo, S., Giordano, A., Gambassi, G., … Gasbarrini, G. (1997). Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free diet. Journal of Internal Medicine, 242(5), 421–3. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9408073

Dohan, F. C. (n.d.). The possible pathogenic effect of cereal grains in schizophrenia. Acta Neurologica, 31(2), 195–205. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1007983

Dohan, F. C. (1988). Genetic hypothesis of idiopathic schizophrenia: its exorphin connection. Schizophrenia Bulletin, 14(4), 489–94. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/2851166

Endres, D., Dersch, R., Stich, O., Buchwald, A., Perlov, E., Feige, B., … van Elst, L. T. (2016). Vitamin D Deficiency in Adult Patients with Schizophreniform and Autism Spectrum Syndromes: A One-Year Cohort Study at a German Tertiary Care Hospital. Frontiers in Psychiatry, 7, 168. http://doi.org/10.3389/fpsyt.2016.00168

Eyles, D. W., Feron, F., Cui, X., Kesby, J. P., Harms, L. H., Ko, P., … Burne, T. H. J. (2009). Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology, 34, S247–S257. http://doi.org/10.1016/j.psyneuen.2009.04.015

Foster, A., Gable, J., & Buckley, J. (2012). Homelessness in Schizophrenia. Psychiatric Clinics of North America, 35(3), 717–734. http://doi.org/10.1016/j.psc.2012.06.010

Geretsegger, M., Mössler, K. A., Bieleninik, Ł., Chen, X.-J., Heldal, T. O., & Gold, C. (2017). Music therapy for people with schizophrenia and schizophrenia-like disorders. In C. Gold (Ed.), Cochrane Database of Systematic Reviews (Vol. 5, p. CD004025). Chichester, UK: John Wiley & Sons, Ltd. http://doi.org/10.1002/14651858.CD004025.pub4

Gorczynski, P., & Faulkner, G. (2010). Exercise therapy for schizophrenia. The Cochrane Database of Systematic Reviews, (5), CD004412. http://doi.org/10.1002/14651858.CD004412.pub2

Hodgins, S. (2008). Violent behaviour among people with schizophrenia: a framework for investigations of causes, and effective treatment, and prevention. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 363(1503), 2505–18. http://doi.org/10.1098/rstb.2008.0034

Horrobin, D. F. (1998). The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophrenia Research, 30(3), 193–208. http://doi.org/10.1016/S0920-9964(97)00151-5

Horrobin, D. F. (2001). The madness of Adam and Eve : how schizophrenia shaped humanity. Bantam.

Kalaydjian, A. E., Eaton, W., Cascella, N., & Fasano, A. (2006). The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatrica Scandinavica, 113(2), 82–90. http://doi.org/10.1111/j.1600-0447.2005.00687.x

Kavak, F., Ünal, S., & Yılmaz, E. (2016). Effects of Relaxation Exercises and Music Therapy on the Psychological Symptoms and Depression Levels of Patients with Schizophrenia. Archives of Psychiatric Nursing, 30(5), 508–512. http://doi.org/10.1016/j.apnu.2016.05.003

Keller, M. C., & Miller, G. (2006). Resolving the paradox of common, harmful, heritable mental disorders: Which evolutionary genetic models work best? Behavioral and Brain Sciences, 29(4). http://doi.org/10.1017/S0140525X06009095

Kovács, Z., Kis, R., Rózsa, S., & Rózsa, L. (2004). Animal-assisted therapy for middle-aged schizophrenic patients living in a social institution. A pilot study. Clinical Rehabilitation, 18(5), 483–486. http://doi.org/10.1191/0269215504cr765oa

Kraeuter, A. K., Loxton, H., Lima, B. C., Rudd, D., & Sarnyai, Z. (2015). Ketogenic diet reverses behavioral abnormalities in an acute NMDA receptor hypofunction model of schizophrenia. Schizophrenia Research, 169(1–3), 491–493. http://doi.org/10.1016/j.schres.2015.10.041

Kraft, B. D., & Westman, E. C. (2009). Schizophrenia, gluten, and low-carbohydrate, ketogenic diets: a case report and review of the literature. Nutrition & Metabolism, 6, 10. http://doi.org/10.1186/1743-7075-6-10

Martin, L. A. L., Koch, S. C., Hirjak, D., & Fuchs, T. (2016). Overcoming Disembodiment: The Effect of Movement Therapy on Negative Symptoms in Schizophrenia-A Multicenter Randomized Controlled Trial. Frontiers in Psychology, 7, 483. http://doi.org/10.3389/fpsyg.2016.00483

McGrath, J., Saari, K., Hakko, H., Jokelainen, J., Jones, P., Järvelin, M.-R., … Isohanni, M. (2004). Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophrenia Research, 67(2–3), 237–45. http://doi.org/10.1016/j.schres.2003.08.005

McGrath, J., Saha, S., Chant, D., & Welham, J. (2008). Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality. Epidemiologic Reviews, 30(1), 67–76. http://doi.org/10.1093/epirev/mxn001

Mitra, S., Natarajan, R., Ziedonis, D., & Fan, X. (2017). Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 78, 1–11. http://doi.org/10.1016/j.pnpbp.2017.05.005

National Collaborating Centre for Mental Health. (2014). Psychosis and Schizophrenia in Adults: The NICE Guideline on Treatment and Management 2014. Retrieved from https://www.nice.org.uk/guidance/cg178/evidence/full-guideline-490503565

Nurenberg, J. R., Schleifer, S. J., Shaffer, T. M., Yellin, M., Desai, P. J., Amin, R., … Montalvo, C. (2015). Animal-Assisted Therapy With Chronic Psychiatric Inpatients: Equine-Assisted Psychotherapy and Aggressive Behavior. Psychiatric Services, 66(1), 80–86. http://doi.org/10.1176/appi.ps.201300524

PACHECO, A., EASTERLING, W. S., & PRYER, M. W. (1965). A PILOT STUDY OF THE KETOGENIC DIET IN SCHIZOPHRENIA. American Journal of Psychiatry, 121(11), 1110–1111. http://doi.org/10.1176/ajp.121.11.1110

Pawełczyk, T., Grancow-Grabka, M., Kotlicka-Antczak, M., Trafalska, E., & Pawełczyk, A. (2016). A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia. Journal of Psychiatric Research, 73, 34–44. http://doi.org/10.1016/j.jpsychires.2015.11.013

Pearlson, G. D., & Folley, B. S. (2007). Schizophrenia, Psychiatric Genetics, and Darwinian Psychiatry: An Evolutionary Framework. Schizophrenia Bulletin, 34(4), 722–733. http://doi.org/10.1093/schbul/sbm130

Polimeni, J., & Reiss, J. P. (2003). Evolutionary Perspectives on Schizophrenia. The Canadian Journal of Psychiatry, 48(1), 34–39. http://doi.org/10.1177/070674370304800107

Power, R. A., Steinberg, S., Bjornsdottir, G., Rietveld, C. A., Abdellaoui, A., Nivard, M. M., … Stefansson, K. (2015). Polygenic risk scores for schizophrenia and bipolar disorder predict creativity. Nature Neuroscience, 18(7), 953–955. http://doi.org/10.1038/nn.4040

Puri, B. K., & Richardson, A. J. (1998). Sustained remission of positive and negative symptoms of schizophrenia following treatment with eicosapentaenoic acid. Archives of General Psychiatry, 55(2), 188–9. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9477938

Puri, B. K., Richardson, A. J., Horrobin, D. F., Easton, T., Saeed, N., Oatridge, A., … Bydder, G. M. (n.d.). Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalisation of blood fatty acids, reduced neuronal membrane phospholipid turnover and structural brain changes. International Journal of Clinical Practice, 54(1), 57–63. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10750263

Rajapakse, R., Mousli, M., Pfaff, A. W., Uring-Lambert, B., Marcellin, L., Bronner, C., … Candolfi, E. (2005). 1,25-Dihydroxyvitamin D3 induces splenocyte apoptosis and enhances BALB/c mice sensitivity to toxoplasmosis. The Journal of Steroid Biochemistry and Molecular Biology, 96(2), 179–185. http://doi.org/10.1016/j.jsbmb.2005.03.002

Remberk, B. (2017). Clinical significance of psychotic-like experiences in children and adolescents. Psychiatria Polska, 51(2), 271–282. http://doi.org/10.12740/PP/63894

RÖHRICHT, F., & PRIEBE, S. (2006). Effect of body-oriented psychological therapy on negative symptoms in schizophrenia: a randomized controlled trial. Psychological Medicine, 36(5), 669. http://doi.org/10.1017/S0033291706007161

Samaroo, D., Dickerson, F., Kasarda, D. D., Green, P. H. R., Briani, C., Yolken, R. H., & Alaedini, A. (2010). Novel immune response to gluten in individuals with schizophrenia. Schizophrenia Research, 118(1–3), 248–255. http://doi.org/10.1016/j.schres.2009.08.009

Severance, E. G., Kannan, G., Gressitt, K. L., Xiao, J., Alaedini, A., Pletnikov, M. V., & Yolken, R. H. (2012). Anti-Gluten Immune Response following Toxoplasma gondii Infection in Mice. PLoS ONE, 7(11), e50991. http://doi.org/10.1371/journal.pone.0050991

Severance, E. G., Yolken, R. H., & Eaton, W. W. (2016). Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophrenia Research, 176(1), 23–35. http://doi.org/10.1016/j.schres.2014.06.027

Sheikhmoonesi, F., Zarghami, M., Mamashli, S., Yazdani Charati, J., Hamzehpour, R., Fattahi, S., … Hendouei, N. (2016). Effectiveness of Vitamin D Supplement Therapy in Chronic Stable Schizophrenic Male Patients: A Randomized Controlled Trial. Iranian Journal of Pharmaceutical Research : IJPR, 15(4), 941–950. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/28243293

Silverstein, S. M., Del Pozzo, J., Roché, M., Boyle, D., & Miskimen, T. (2015). Schizophrenia and violence: realities and recommendations. Crime Psychology Review, 1(1), 21–42. http://doi.org/10.1080/23744006.2015.1033154

Strobl, J. S., Goodwin, D. G., Rzigalinski, B. a, & Lindsay, D. S. (2012). Dopamine stimulates propagation of Toxoplasma gondii tachyzoites in human fibroblast and primary neonatal rat astrocyte cell cultures. The Journal of Parasitology, 98(6), 1296–9. http://doi.org/10.1645/GE-2760.1

Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003). Schizophrenia as a Complex Trait. Archives of General Psychiatry, 60(12), 1187. http://doi.org/10.1001/archpsyc.60.12.1187

Torda, A. (2001). Are cats really the source?, 30(8), 743–748.

Uher, R. (2009). The role of genetic variation in the causation of mental illness: an evolution-informed framework. Molecular Psychiatry, 14(12), 1072–82. http://doi.org/10.1038/mp.2009.85

Valipour, G., Saneei, P., & Esmaillzadeh, A. (2014). Serum Vitamin D Levels in Relation to Schizophrenia: A Systematic Review and Meta-Analysis of Observational Studies. The Journal of Clinical Endocrinology & Metabolism, 99(10), 3863–3872. http://doi.org/10.1210/jc.2014-1887

Vilhauer, R. P. (2015). Depictions of auditory verbal hallucinations in news media. International Journal of Social Psychiatry, 61(1), 58–63. http://doi.org/10.1177/0020764014535757

Wallace, C., Mullen, P. E., & Burgess, P. (2004). Criminal Offending in Schizophrenia Over a 25-Year Period Marked by Deinstitutionalization and Increasing Prevalence of Comorbid Substance Use Disorders. American Journal of Psychiatry, 161(4), 716–727. http://doi.org/10.1176/appi.ajp.161.4.716

Webster, J. P., Kaushik, M., Bristow, G. C., & McConkey, G. a. (2013). Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour? The Journal of Experimental Biology, 216(Pt 1), 99–112. http://doi.org/10.1242/jeb.074716

Whitford, V., O’Driscoll, G. A., & Titone, D. (2017). Reading deficits in schizophrenia and their relationship to developmental dyslexia: A review. Schizophrenia Research. http://doi.org/10.1016/j.schres.2017.06.049

Yee, J. Y., See, Y. M., Abdul Rashid, N. A., Neelamekam, S., & Lee, J. (2016). Association between serum levels of bioavailable vitamin D and negative symptoms in first-episode psychosis. Psychiatry Research, 243, 390–394. http://doi.org/10.1016/j.psychres.2016.07.003